Literature DB >> 24669933

Evaluation of the national prevention program in iran, 2007-2009: the accomplishments and challenges with reflections on the path ahead.

Mahmoud Hadipour Dehshal1, Mehdi Tabrizi Namini, Alireza Ahmadvand, Mohsen Manshadi, Forouzan Sadeghian Varnosfaderani, Hassan Abolghasemi.   

Abstract

β-Thalassemia major (β-TM) is an inherited disease and efforts have been made in several countries to reduce the number of affected births. In the present study, we aimed to evaluate the Iranian thalassemia prevention program, considered to be an important program in the region. The time period of the present study ranges from 2007-2009, during which new thalassemic births and the relevant causes were evaluated throughout the country. A cross-sectional analytical study was conducted at the Iranian Blood Transfusion Organization (IBTO), Tehran, Iran. A questionnaire was forwarded to all blood centers of the IBTO so as to obtain information about the new cases of thalassemia and the causes of these thalassemic births. Provincial thalassemia societies also received the questionnaires so that screening and prenatal diagnosis (PND) errors would be recorded. The results showed that 755 new thalassemia cases were born during 2007-2009 with the average fall in affected thalassemia births of 80.82%. The main cause of the new births was attributed to unregistered "timeless religious marriages" based on the conventions of the Sunni community which accounted for 43.17% of all new cases mainly having occurred in Sistan & Baluchestan Province. Not using PND was evaluated to be another main cause. Although the prevention program has led to a great reduction in thalassemic births, new measures are required, including research on how to make the program compatible with social and economic conventions and norms of Sistan & Baluchestan Province. The province of Kohgiluyeh Boyer Ahmad also needs to be revisited in terms of the program efficacy.

Entities:  

Keywords:  Causes of new thalassemia cases; Iranian Thalassaemia Prevention Programme; fall in affected birth rates; prenatal diagnosis; prevention of thalassemia; thalassemia

Mesh:

Year:  2014        PMID: 24669933     DOI: 10.3109/03630269.2014.893530

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  6 in total

1.  Decisional conflict and regret: shared decision-making about pregnancy affected by β-thalassemia major in Southeast of Iran.

Authors:  Zahra Moudi; Zenab Phanodi; Hossein Ansari; Mostafa Montazer Zohour
Journal:  J Hum Genet       Date:  2017-12-22       Impact factor: 3.172

2.  Decisions Regarding Pregnancy Termination Due to β-Thalassemia Major: a Mixed-Methods Study in Sistan and Baluchestan, Iran.

Authors:  Zahra Moudi; Ebrahim Miri-Moghaddam
Journal:  J Genet Couns       Date:  2016-09-28       Impact factor: 2.537

3.  A Large Cohort Study of Genotype and Phenotype Correlations of Beta- Thalassemia in Iranian Population.

Authors:  Fereshteh Maryami; Azita Azarkeivan; Mohammad Sadegh Fallah; Sirous Zeinali
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2015-10-01

Review 4.  The Iran Thalassemia Prevention Program: Success or Failure?

Authors:  M Hashemieh; H Timori Naghadeh; M Tabrizi Namini; H Neamatzadeh; M Hadipour Dehshal
Journal:  Iran J Ped Hematol Oncol       Date:  2015-07-20

5.  Haematological and electrophoretic characterisation of β-thalassaemia in Yunnan province of Southwestern China.

Authors:  Jie Zhang; Jing He; Xiaoqin Mao; Xiaohong Zeng; Hong Chen; Jie Su; Baosheng Zhu
Journal:  BMJ Open       Date:  2017-01-31       Impact factor: 2.692

6.  Global Globin Network Consensus Paper: Classification and Stratified Roadmaps for Improved Thalassaemia Care and Prevention in 32 Countries.

Authors:  Bin Hashim Halim-Fikri; Carsten W Lederer; Atif Amin Baig; Siti Nor Assyuhada Mat-Ghani; Sharifah-Nany Rahayu-Karmilla Syed-Hassan; Wardah Yusof; Diana Abdul Rashid; Nurul Fatihah Azman; Suthat Fucharoen; Ramdan Panigoro; Catherine Lynn T Silao; Vip Viprakasit; Norunaluwar Jalil; Norafiza Mohd Yasin; Rosnah Bahar; Veena Selvaratnam; Norsarwany Mohamad; Nik Norliza Nik Hassan; Ezalia Esa; Amanda Krause; Helen Robinson; Julia Hasler; Coralea Stephanou; Raja-Zahratul-Azma Raja-Sabudin; Jacques Elion; Ghada El-Kamah; Domenico Coviello; Narazah Yusoff; Zarina Abdul Latiff; Chris Arnold; John Burn; Petros Kountouris; Marina Kleanthous; Raj Ramesar; Bin Alwi Zilfalil
Journal:  J Pers Med       Date:  2022-03-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.